Related Experiment Video
Updated: Jul 5, 2026

17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Integrating toxicology into cosmetic ingredient research and development
1Ciba Specialty Chemicals Corporation, 4090 Premier Drive, High Point, North Carolina 27265, USA.
International Journal of Cosmetic Science
|May 24, 2008
Summary
Integrating early toxicity testing into cosmetic ingredient research and development (R&D) prevents costly setbacks. This approach ensures ingredients have market potential by identifying safety concerns sooner.
Area of Science:
- Cosmetic Science
- Toxicology
- Chemical Research & Development
Background:
- Cosmetic ingredient development traditionally delays toxicity assessment until late stages of research and development (R&D).
- Late-stage toxicity identification can result in significant R&D investment loss, market restrictions, or complete ingredient abandonment.
- This inefficiency highlights the need for a revised R&D framework.
Purpose of the Study:
- To propose a novel, tiered approach for integrating toxicology assessments early into the cosmetic ingredient R&D lifecycle.
- To enhance the efficiency and cost-effectiveness of developing new cosmetic ingredients.
- To mitigate risks associated with late-stage toxicity findings.
Main Methods:
- A flexible, tiered strategy for incorporating toxicology into the R&D process is presented.
- The approach emphasizes leveraging readily available resources for phased safety evaluations.
- The methodology focuses on early-stage risk identification and mitigation.
Main Results:
- Early integration of toxicity assessment can significantly improve R&D efficiency.
- A proactive approach helps avoid the development of ingredients with limited market viability due to safety concerns.
- The tiered system allows for adaptable resource allocation throughout the R&D pipeline.
Conclusions:
- Implementing a tiered toxicology assessment early in cosmetic ingredient R&D is crucial.
- This strategy optimizes resource utilization and minimizes the risk of market rejection.
- Proactive safety evaluation supports the development of viable and safe cosmetic ingredients.
More Related Videos
Related Concept Videos
Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

